Table 1:

Endovascular treatment and devices used

Case No.	Occlusion Sites	Spasmolytic Agents	Timing of Drug Therapy	Mechanical Device	No. of Balloon Inflations
1	L M2	ReoPro	Post	Merci	3
				Maverick, 2 × 9 mm, Neuroform 2
2	L M2/M3 bifurcation	ReoPro, Activase	Intra, Post	Maverick, 1.5 × 9 mm	2
	L M2
3	L M3	ReoPro	Post	Maverick, 2.5 × 15 mm, Wingspan, Enterprise	2
	L M2/M3 bifurcation
4	L M3	ReoPro	Pre	Maverick, 2.0 × 15 mm	4
	L M2
	L M1
5	L M2	ReoPro	Post	Merci	2
	L M1			Maverick, 1.5 × 20 mm
6	R M3	Alteplase	Pre, Intra	Maverick, 1.5 × 9 mm	4
	R M2
7	R M3	IV rtPA,^a ReoPro, nitroglycerin	Post	Maverick, 1.5 × 15 mm	3

a rtPA given in the ED at 2.5 hours after onset of symptoms; patient received endovascular treatment due to persistence of neurologic symptoms.